פוטאקטזול 1 מ"ג

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

TOPOTECAN HYDROCHLORIDE 1 MG

Disponible depuis:

DEVRIES & CO. LTD

Code ATC:

L01XX17

forme pharmaceutique:

POWDER FOR CONCENTRATE FOR SOUTION FOR INFUSION

Mode d'administration:

I.V

Fabriqué par:

ACTAVIS GROUP PTC ehf, ICELAND

Groupe thérapeutique:

TOPOTECAN

indications thérapeutiques:

Treatment of metastatic carcinoma of the ovary after failure of initial or subsequent therapy. Treatment of small cell lung cancer sensitive disease after failure of first line chemotherapy. Topotecan in combination with cisplatin is indicated for the treatment of Stage IV-B recurrent or persistent carcinoma of the cervix which is not amenable to curative treatment with surgery and/or radiation therapy.

Date de l'autorisation:

2012-12-01